AFP and hepatocellular carcinoma: In addition, analysis of changes in serum AFP levels and patient survival was performed.<h4>Methods</h4>A retrospective study of 459 HCC patients treated with one of the aforementioned treatments was performed: TACE-MI ( N = 305) and TACE-HAIC-MI ( N = 154).